- Home
- Publications
- Publication Search
- Publication Details
Title
High Mobility Group Box-1 and Blood–Brain Barrier Disruption
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 12, Pages 2650
Publisher
MDPI AG
Online
2020-12-11
DOI
10.3390/cells9122650
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HMGB1 Translocation in Neurons after Ischemic Insult: Subcellular Localization in Mitochondria and Peroxisomes
- (2020) Dengli Wang et al. Cells
- Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures
- (2020) Robert D. Nass et al. EPILEPSY RESEARCH
- Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
- (2020) Ulf Andersson et al. MOLECULAR MEDICINE
- Targeting Inflammation Driven by HMGB1
- (2020) Huan Yang et al. Frontiers in Immunology
- Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients
- (2020) Liting Chen et al. Cellular & Molecular Immunology
- HMGB1 promoted P-glycoprotein at the blood-brain barrier in MCAO rats via TLR4/NF-κB signaling pathway
- (2020) Fei Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Role of Neurovascular System in Neurodegenerative Diseases
- (2020) Ajmal Ahmad et al. MOLECULAR NEUROBIOLOGY
- Histidine-Rich Glycoprotein Inhibits High-Mobility Group Box-1-Mediated Pathways in Vascular Endothelial Cells through CLEC-1A
- (2020) Shangze Gao et al. iScience
- Prognostic value of plasma HMGB1 in ischemic stroke patients with cerebral ischemia-reperfusion injury after intravenous thrombolysis
- (2020) Jia Wang et al. Journal of Stroke & Cerebrovascular Diseases
- Proteomic Quantification of Human Blood–Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients
- (2019) Zubida M. Al-Majdoub et al. MOLECULAR PHARMACEUTICS
- Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases
- (2019) Masahiro Nishibori et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis
- (2019) Rana Abdul Razzak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-mobility group box 1-mediated microglial activation induces anxiodepressive-like behaviors in mice with neuropathic pain
- (2019) Kazue Hisaoka-Nakashima et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Developmental changes in transporter and receptor protein expression levels at the rat blood-brain barrier based on quantitative targeted absolute proteomics
- (2019) Kotaro Omori et al. Drug Metabolism and Pharmacokinetics
- Detrimental Effects of HMGB-1 Require Microglial-Astroglial Interaction: Implications for the Status Epilepticus -Induced Neuroinflammation
- (2019) Gerardo Rosciszewski et al. Frontiers in Cellular Neuroscience
- Small Vessels Are a Big Problem in Neurodegeneration and Neuroprotection
- (2019) Şefik Evren Erdener et al. Frontiers in Neurology
- HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways
- (2019) Xie et al. Biomolecules
- Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences
- (2019) Kyria M. Webster et al. EXPERIMENTAL NEUROLOGY
- Predicting post-stroke pneumonia using deep neural network approaches
- (2019) Yanqiu Ge et al. INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
- HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window
- (2019) Junli Zhao et al. Neurotherapeutics
- Risk Factors for Depression: An Autobiographical Review
- (2018) Constance Hammen Annual Review of Clinical Psychology
- Persistent Increase in Microglial RAGE Contributes to Chronic Stress–Induced Priming of Depressive-like Behavior
- (2018) Tina C. Franklin et al. BIOLOGICAL PSYCHIATRY
- DNA binding protein HMGB1 secreted by activated microglia promotes the apoptosis of hippocampal neurons in diabetes complicated with OSA
- (2018) Yu Shi et al. BRAIN BEHAVIOR AND IMMUNITY
- High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy
- (2018) Teresa Ravizza et al. BRAIN BEHAVIOR AND IMMUNITY
- Depression and sterile inflammation: Essential role of danger associated molecular patterns
- (2018) Tina C. Franklin et al. BRAIN BEHAVIOR AND IMMUNITY
- HMGB1 a-Box Reverses Brain Edema and Deterioration of Neurological Function in a Traumatic Brain Injury Mouse Model
- (2018) Lijun Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4/MyD88 pathway
- (2018) Xiao Cheng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Anti-high mobility group box-1 monoclonal antibody treatment of brain edema induced by influenza infection and lipopolysaccharide
- (2018) Nobuyuki Nosaka et al. JOURNAL OF MEDICAL VIROLOGY
- Identification and Quantification of Blood-Brain Barrier Transporters in Isolated Rat Brain Microvessels
- (2018) Hajar Al Feteisi et al. JOURNAL OF NEUROCHEMISTRY
- HMGB1 promotes the starvation-induced autophagic degradation of α-synuclein in SH-SY5Y cells Atg 5-dependently
- (2018) Yi Guan et al. LIFE SCIENCES
- Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
- (2018) Melanie D. Sweeney et al. Nature Reviews Neurology
- Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy
- (2018) Aaron Dadas et al. NEUROBIOLOGY OF DISEASE
- Therapeutic time window of anti-high mobility group box-1 antibody administration in mouse model of spinal cord injury
- (2018) Masahide Nakajo et al. NEUROSCIENCE RESEARCH
- Neuroimmune Axes of the Blood–Brain Barriers and Blood–Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions
- (2018) Michelle A. Erickson et al. PHARMACOLOGICAL REVIEWS
- Prior Treatment with Anti-High Mobility Group Box-1 Antibody Boosts Human Neural Stem Cell Transplantation-Mediated Functional Recovery After Spinal Cord Injury
- (2018) Naohiro Uezono et al. STEM CELLS
- Alarmin HMGB1 induces systemic and brain inflammatory exacerbation in post-stroke infection rat model
- (2018) Il-Doo Kim et al. Cell Death & Disease
- Dynamic Remodeling of Pericytes In Vivo Maintains Capillary Coverage in the Adult Mouse Brain
- (2018) Andrée-Anne Berthiaume et al. Cell Reports
- Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release
- (2018) Yan Sun et al. Frontiers in Immunology
- Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage
- (2018) Airton Leonardo de Oliveira Manoel et al. Frontiers in Neurology
- Ursolic Acid Ameliorates Inflammation in Cerebral Ischemia and Reperfusion Injury Possibly via High Mobility Group Box 1/Toll-Like Receptor 4/NFκB Pathway
- (2018) Yanzhe Wang et al. Frontiers in Neurology
- Targeting pericytes for therapeutic approaches to neurological disorders
- (2018) Jinping Cheng et al. ACTA NEUROPATHOLOGICA
- Berberine attenuates ischemia–reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation
- (2018) Jun-rong Zhu et al. ACTA PHARMACOLOGICA SINICA
- Lack of Benefit on Brain Edema, Blood–Brain Barrier Permeability, or Cognitive Outcome in Global Inducible High Mobility Group Box 1 Knockout Mice Despite Tissue Sparing after Experimental Traumatic Brain Injury
- (2018) Rajesh K. Aneja et al. JOURNAL OF NEUROTRAUMA
- Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk
- (2018) Fumiko Sekiguchi et al. NEUROPHARMACOLOGY
- Differential Roles of Mitochondrial Translocation of Active Caspase-3 and HMGB1 in Neuronal Death Induced by Status Epilepticus
- (2018) Ji-Eun Kim et al. Frontiers in Cellular Neuroscience
- HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
- (2018) Yam Nath Paudel et al. Frontiers in Neuroscience
- Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease
- (2018) Kirsty E. McAleese et al. BRAIN PATHOLOGY
- High-mobility group box-1 translocation and release after hypoxic ischemic brain injury in neonatal rats
- (2018) Xiaodi Chen et al. EXPERIMENTAL NEUROLOGY
- The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis
- (2018) Meihong Deng et al. IMMUNITY
- Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus
- (2018) Ya-jun Li et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Blood-Brain Barrier: From Physiology to Disease and Back
- (2018) Melanie D. Sweeney et al. PHYSIOLOGICAL REVIEWS
- Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
- (2017) Axel Montagne et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury
- (2017) Xiangrong Chen et al. Journal of Neuroinflammation
- Elevated Serum High-Mobility Group Box-1 Protein Level Is Associated with Poor Functional Outcome in Ischemic Stroke
- (2017) Toshiyuki Tsukagawa et al. Journal of Stroke & Cerebrovascular Diseases
- HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains via the RAGE/NF-κB signaling pathway
- (2017) Yuan Xie et al. Molecular Medicine Reports
- Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
- (2017) Kassandra Kisler et al. NATURE REVIEWS NEUROSCIENCE
- The blood-brain barrier in Alzheimer's disease
- (2017) Elena Zenaro et al. NEUROBIOLOGY OF DISEASE
- Glycyrrhizic acid exerts anti-inflammatory effect to improve cerebral vasospasm secondary to subarachnoid hemorrhage in a rat model
- (2017) Yi Li et al. NEUROLOGICAL RESEARCH
- The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
- (2017) Costantino Iadecola NEURON
- Ultra-Early Phase pathologies of Alzheimer’s disease and other neurodegenerative diseases
- (2017) Hitoshi OKAZAWA PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- CD146 coordinates brain endothelial cell–pericyte communication for blood–brain barrier development
- (2017) Jianan Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice
- (2017) Li Fu et al. Scientific Reports
- Elevated Serum High-Mobility Group Box-1 Protein Level Is Associated with Poor Functional Outcome in Ischemic Stroke
- (2017) Toshiyuki Tsukagawa et al. Journal of Stroke & Cerebrovascular Diseases
- Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats
- (2017) Dengli Wang et al. Scientific Reports
- Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior
- (2016) Yuyan Cheng et al. BRAIN BEHAVIOR AND IMMUNITY
- Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review
- (2016) M. Veldeman et al. BRITISH JOURNAL OF ANAESTHESIA
- Beclin1 and HMGB1 ameliorate the α-synuclein-mediated autophagy inhibition in PC12 cells
- (2016) Kaihua Wang et al. Diagnostic Pathology
- Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease
- (2016) Tatsuya Sasaki et al. EXPERIMENTAL NEUROLOGY
- Expression of high-mobility group box-1 (HMGB1) in the basilar artery after experimental subarachnoid hemorrhage
- (2016) Xu Dong Zhao et al. JOURNAL OF CLINICAL NEUROSCIENCE
- HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
- (2016) Barry W. Festoff et al. Journal of Neuroinflammation
- Pericytes as Inducers of Rapid, Matrix Metalloproteinase-9-Dependent Capillary Damage during Ischemia
- (2016) Robert G. Underly et al. JOURNAL OF NEUROSCIENCE
- Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice
- (2016) Yoshihiko Nakamura et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Inhibiting HMGB1 with Glycyrrhizic Acid Protects Brain Injury after DAI via Its Anti-Inflammatory Effect
- (2016) Honggang Pang et al. MEDIATORS OF INFLAMMATION
- Translocation and dissemination of commensal bacteria in post-stroke infection
- (2016) Dragana Stanley et al. NATURE MEDICINE
- Pericytes of the neurovascular unit: key functions and signaling pathways
- (2016) Melanie D Sweeney et al. NATURE NEUROSCIENCE
- In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
- (2016) Matteo Santoro et al. NEUROBIOLOGY OF DISEASE
- Mitochondrial Translocation of High Mobility Group Box 1 Facilitates LIM Kinase 2-Mediated Programmed Necrotic Neuronal Death
- (2016) Hye-Won Hyun et al. Frontiers in Cellular Neuroscience
- Pericytes in Brain Injury and Repair After Ischemic Stroke
- (2016) Wei Cai et al. Translational Stroke Research
- Histidine-Rich Glycoprotein Prevents Septic Lethality through Regulation of Immunothrombosis and Inflammation
- (2016) Hidenori Wake et al. EBioMedicine
- HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease
- (2016) Kyota Fujita et al. Scientific Reports
- Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats
- (2016) Jun Haruma et al. Scientific Reports
- Establishment and Dysfunction of the Blood-Brain Barrier
- (2015) Zhen Zhao et al. CELL
- Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloprotease-9 up-regulation in mice with painful peripheral neuropathy
- (2015) Fang Fang Zhang et al. JOURNAL OF NEUROCHEMISTRY
- Aβ1-42oligomer-induced leakage in anin vitroblood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins
- (2015) Wenbin Wan et al. JOURNAL OF NEUROCHEMISTRY
- Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit
- (2015) William A. Banks et al. Journal of Neuroinflammation
- HMGB1 Level in Cerebrospinal Fluid as a Marker of Treatment Outcome in Patients with Acute Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage
- (2015) Bartosz Sokół et al. Journal of Stroke & Cerebrovascular Diseases
- Vascular dysfunction in the pathogenesis of Alzheimer's disease — A review of endothelium-mediated mechanisms and ensuing vicious circles
- (2015) Luigi Yuri Di Marco et al. NEUROBIOLOGY OF DISEASE
- Brain pericytes are the most thrombin-sensitive matrix metalloproteinase-9-releasing cell type constituting the blood–brain barrier in vitro
- (2015) Takashi Machida et al. NEUROSCIENCE LETTERS
- HMGB1 Level in Cerebrospinal Fluid as a Marker of Treatment Outcome in Patients with Acute Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage
- (2015) Bartosz Sokół et al. Journal of Stroke & Cerebrovascular Diseases
- Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome
- (2014) Nelly Sapojnikova et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Glycyrrhizin protects brain against ischemia–reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway
- (2014) Jiancheng Zhang et al. BRAIN RESEARCH
- PARP-1 Mediates LPS-Induced HMGB1 Release by Macrophages through Regulation of HMGB1 Acetylation
- (2014) Zhiyong Yang et al. JOURNAL OF IMMUNOLOGY
- A Novel, Noninvasive, Predictive Epilepsy Biomarker with Clinical Potential
- (2014) M. Choy et al. JOURNAL OF NEUROSCIENCE
- Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1–RAGE interaction
- (2014) Yu Okuma et al. NEUROPHARMACOLOGY
- Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury
- (2014) Hongju Zhang et al. Cell Death & Disease
- High mobility group box 1 prolongs inflammation and worsens disease in pneumococcal meningitis
- (2013) Christopher Höhne et al. BRAIN
- Glycyrrhizin protects spinal cord and reduces inflammation in spinal cord ischemia–reperfusion injury
- (2013) Bin Ni et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis
- (2013) Andrew P. Robinson et al. JOURNAL OF AUTOIMMUNITY
- Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials
- (2013) Jian Shen et al. JOURNAL OF NEUROSURGERY
- Delayed neurological deterioration after subarachnoid haemorrhage
- (2013) R. Loch Macdonald Nature Reviews Neurology
- Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures
- (2013) Valentina Iori et al. NEUROBIOLOGY OF DISEASE
- The Pathobiology of Vascular Dementia
- (2013) Costantino Iadecola NEURON
- Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain
- (2013) Joo-Hyun Shin et al. NEUROSCIENCE LETTERS
- Anti-high mobility group box-1 antibody therapy for traumatic brain injury
- (2012) Yu Okuma et al. ANNALS OF NEUROLOGY
- Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage
- (2012) Laura Librizzi et al. ANNALS OF NEUROLOGY
- Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury
- (2012) Ke-Yi Wang et al. CLINICA CHIMICA ACTA
- Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis
- (2012) A. Uzawa et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Drug Transport across the Blood–Brain Barrier
- (2012) William M Pardridge JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- A 1-42-RAGE Interaction Disrupts Tight Junctions of the Blood-Brain Barrier Via Ca2+-Calcineurin Signaling
- (2012) S.-Y. Kook et al. JOURNAL OF NEUROSCIENCE
- Cerebrospinal Fluid Levels of High-Mobility Group Box 1 and Cytochrome C Predict Outcome after Pediatric Traumatic Brain Injury
- (2012) Alicia K. Au et al. JOURNAL OF NEUROTRAUMA
- Intranasal Delivery of HMGB1 siRNA Confers Target Gene Knockdown and Robust Neuroprotection in the Postischemic Brain
- (2012) Il-Doo Kim et al. MOLECULAR THERAPY
- Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain
- (2012) Takashi Shichita et al. NATURE MEDICINE
- Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion
- (2012) Seung-Woo Kim et al. NEUROBIOLOGY OF DISEASE
- Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica
- (2012) K.-C. Wang et al. NEUROSCIENCE
- High-mobility group box1 protein promotes neuroinflammation after intracerebral hemorrhage in rats
- (2012) C. Lei et al. NEUROSCIENCE
- Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain
- (2012) Il-Doo Kim et al. NEUROSCIENCE LETTERS
- Post-Ischemic Inflammation in the Brain
- (2012) Takashi Shichita et al. Frontiers in Immunology
- Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1
- (2011) Gu Gong et al. ACTA PHARMACOLOGICA SINICA
- Resolving postoperative neuroinflammation and cognitive decline
- (2011) Niccolò Terrando et al. ANNALS OF NEUROLOGY
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
- (2011) Ulf Andersson et al. Annual Review of Immunology
- Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
- (2011) Annika Armulik et al. DEVELOPMENTAL CELL
- Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-α, releasing matrix metalloproteinase-9 and migrating in vitro
- (2011) Fuyuko Takata et al. Journal of Neuroinflammation
- Beneficial Effects of Ethyl Pyruvate through Inhibiting High-Mobility Group Box 1 Expression and TLR4/NF-κB Pathway after Traumatic Brain Injury in the Rat
- (2011) Xingfen Su et al. MEDIATORS OF INFLAMMATION
- HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats
- (2011) Masatoshi Ohnishi et al. NEUROPHARMACOLOGY
- Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood–Brain Barrier From Ischemia-Induced Disruption in Rats
- (2011) Jiyong Zhang et al. STROKE
- Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model
- (2010) Fumie Konoeda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-κB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia
- (2010) Lina Wang et al. BRAIN RESEARCH
- Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage
- (2010) Jean-Pierre Louboutin et al. FASEB JOURNAL
- Elevation of High-Mobility Group Protein Box-1 in Serum Correlates with Severity of Acute Intracerebral Hemorrhage
- (2010) Yu Zhou et al. MEDIATORS OF INFLAMMATION
- Pericytes regulate the blood–brain barrier
- (2010) Annika Armulik et al. NATURE
- Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures
- (2010) Mattia Maroso et al. NATURE MEDICINE
- Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury
- (2010) Dan Shlosberg et al. Nature Reviews Neurology
- Inflammation and Cerebral Vasospasm After Subarachnoid Hemorrhage
- (2010) Gustavo Pradilla et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Ethyl Pyruvate Attenuates Spinal Cord Ischemic Injury with a Wide Therapeutic Window through Inhibiting High-mobility Group Box 1 Release in Rabbits
- (2009) Qiang Wang et al. ANESTHESIOLOGY
- Blood–brain barrier breakdown-inducing astrocytic transformation: Novel targets for the prevention of epilepsy
- (2009) Alon Friedman et al. EPILEPSY RESEARCH
- Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery
- (2009) Muge Yemisci et al. NATURE MEDICINE
- Structure and function of the blood–brain barrier
- (2009) N. Joan Abbott et al. NEUROBIOLOGY OF DISEASE
- High-Mobility Group Box 1 Protein in CSF of Patients with Subarachnoid Hemorrhage
- (2009) Takashi Nakahara et al. Neurocritical Care
- Peri-operative measures for treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage
- (2009) Ali Alaraj et al. NEUROLOGICAL RESEARCH
- Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis
- (2008) Åsa Andersson et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid- -Mediated Cortical Synaptic Dysfunction
- (2008) N. Origlia et al. JOURNAL OF NEUROSCIENCE
- Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage
- (2007) Y Maeda et al. BRITISH JOURNAL OF PHARMACOLOGY
- Induction and subcellular localization of high-mobility group box–1 (HMGB1) in the postischemic rat brain
- (2007) Jung-Bin Kim et al. JOURNAL OF NEUROSCIENCE RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now